In osteosarcoma, diallyl disulfide (DADS) inhibits FOXM1 expression by activating miR-134, an upstream regulator of FOXM1, thereby reducing cancer cell proliferation and invasion (27). Here, FOXM1 is linked to osteosarcoma.